A prototype neuromuscular diagnostic system (PAINULIM) that diagnoses painful or impaired upper limbs has been developed based on Bayesian networks. This paper presents nonmathematically the major knowledge representation issues that arose in the development of PAINULIM. Motivated by the computational overhead of large application domains, and the desire to provide a user with an interface that gives a focused display of a subdomain of current interest, we built PAINULIM using the idea of multiply sectioned Bayesian networks. A preliminary evaluation of PAINULIM with 76 patients has demonstrated good clinical performance.
1 Introduction nervous system. About 50% of the patients visiting NDU are covered by the domain of PAINULIM. The 14 most common diseases considered include: amyotrophic lateral sclerosis, Parkinsons disease, anterior horn cell disease, root diseases, plexus lesions, intrinsic cord disease, carpal tunnel syndrome, and medial, ulnar and radial nerve lesions.
PAINULIM requires from its users speci c knowledge and experience: (1) minimum competence in clinical medicine especially in neuromuscular diseases; (2) basic knowledge of nerve conduction study techniques; and (3) minimum experience of EMG patterns in common neuromuscular diseases. We have designed PAINULIM with the objective of supporting the following classes of users: (1) students and residents in neurology, physical medicine and neuromuscular diseases; (2) doctors who are practising EMG and nerve conduction studies; (3) experienced EMGers (as a formal peer review/self evaluation); and (4) potentially di erent labs to adapt uniform procedures and criteria for diagnoses.
PAINULIM uses three major information sources to make diagnostic recommendations: clinical examination, (needle) EMG studies, and nerve conduction studies. MUNIN has explored only clinical examination and EMG studies 1], and NEUROP has explored only clinical examination and nerve conduction studies 19]).
Given the level of user competence mentioned above, PAINULIM relies on users to interpret data acquired during EMG and nerve conduction studies, and takes the interpretation as evidence (features) for diagnostic inference. Based on the evidence, PAINULIM computes the posterior probability distributions for each disease hypothesis and feature variables not yet observed.
PAINULIM represents explicitly the clinically signi cant disease-feature relations, which is one of the most important parts of the expertise of experienced EMGers. This choice allowed the rapid development of PAINULIM at the clinical level (versus, for example, the microhuman level). A clinical evaluation of PAINULIM will be presented in the latter part of this paper. The performance at clinical level can then provide us with feedback for further extensions and improvements.
Clinical diagnoses are performed in three steps: anatomical, pathological and etiological. PAINULIM currently works mostly at the anatomical level.
In the development of PAINULIM, two of us (B.P. and A.E.) acted as the domain experts. The network structure and probability values were generated from the subjective assessments supplemented by available medical literature.
Localization In Large Application Domains
PAINULIM is based on a Bayesian network which contains 83 variables representing 14 diseases and 69 features (evidence), each of which has up to three possible outcomes. The network is multiply connected (multiple paths exists between a pair of nodes) and has 271 arcs and 6795 probability values. After the system has performed satisfactorily at the current representation level, we plan to extend its representation, which will pose even greater demands on computational resources. As commonly applied, the Bayesian network representation does not consider domain structure, but rather lumps all variables of a domain into one homogeneous or at network. This is appropriate for small domains. In the development of PAINULIM, such representations con ict with the need for E cient computation, and as a result, short response time in system testing; and moderate space requirements. Rather than asking EMGers to come to powerful workstations, we would like to perform knowledge acquisition and system testing in hospital environments where only PCs are commonly available. We would like to continue running on PCs even when we further elaborate and extend the PAINULIM representation.
A more natural user interface. There are natural stages during diagnosis where EMGers focus their attention on a subdomain. Presenting the overall domain represented by a large Bayesian network to EMGers all the time would distract them with subdomains they are not interested in at the moment. We expand on this point below. We made the following observation on the PAINULIM domain based on the practice in NDU. An EMGer, examining a patient with a painful or impaired upper limb, may temporarily consider only his ndings' implication on a set of disease candidates. He may not start to consider the diagnostic signi cance of each available laboratory test until he has nished the clinical examination. After each clinical nding (about ve ndings for an average patient), he dynamically changes the most likely disease candidates, and based on that, he subsequently chooses another question or laboratory test. After the clinical examination, ndings highlight certain disease candidates and make others less likely, which may suggest that nerve conduction studies are of no help at all, while EMG tests are diagnostically bene cial (in NDU, about 60% of patients receive only EMG tests, and about 27% of patients receive only nerve conduction studies). Faced with many alternatives in EMG tests, the EMGer would not perform a test unless it is considered diagnostically necessary based on results in previous tests. In the NDU of VGH, for an average patient, about six EMG tests are performed, and about four nerve conduction studies are performed.
From this scenario and related statistics, we see the important phenomenon of localization: During the clinical examination, only clinical ndings and disease candidates are of current interest to the EMGer. And during EMG tests, only EMG test results and their implications on a subset of the diseases are the focus of the EMGer's attention. Furthermore, for a large percentage (60%+27%=87%) of patients, only one of either EMG or nerve conduction studies is required, but not both. If the EMGer is assisted by a Bayesian-network-based system, a \small" part of the network would be involved repeatedly for about ve queries during each diagnostic period (the clinical period or the EMG period for the above scenario); and for 87% of patients certain parts of the network (either the EMG portion or the nerve conduction portion) may not be of interest at all. If we can organize the network in a way corresponding to this localization, we can restrict our computation to the area of interest and reduce the computational cost. We can also present the user with only the subdomain of his current attention.
To summarize, by localization, we mean the following: There are xed natural subdomains in large domains with respect to human reasoning activities. At any time, a human reasoner often focuses attention on only one of them. He acquires evidence from and forms queries about one of them at a time. He may shift attention from one to another from time to time. When localization exists, a homogeneous network representation and resultant global propagation of evidence are unnecessary, unnatural and ine cient.
There have been attempts of decomposition of homogeneous Bayesian networks to achieve di erent goals. However, they did not address localization explicitly:
Relevant early work includes a method by Pearl 17] which allows postponing evidence propagation in a hierarchical network of hypotheses. Pruning Bayesian networks with respect to each query instance reduces computational cost 2]. The method does not provide general support for incremental evidence (i.e., all evidence must be entered at one time). Heckerman 10] partitions Bayesian networks into small groups of naturally related variables to ease the construction of large networks. But once the construction is nished, the run time representation is still homogeneous. 
Representation of localization in MSBNs
In practice, a MSBN is constructed one subnet at a time. For the convenience in presenting the concepts, in this section we assume that an UnSectioned Bayesian Network (USBN) is given. Our task is to construct the MSBN/junction forest representation such that localization can be exploited. The following overview summarizes the major technical steps in construction of MSBNs. A simple example is used to illustrate the steps.
The rst step is to identify subdomains according to localization. Suppose variables in the network ( Figure 1 Bayesian subnetwork is abbreviated as subnet throughout the paper.
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A junction tree of a Bayesian network is a tree where each node is labelled with a subset of nodes in . The intersection of any two nodes in this tree is contained in each node on the unique path between them. For a formal de nition of junction trees, see 27]. However, when we place the pair back to the original homogeneous network, the d-sepset is not su cient to guarantee the conditional independence any more. Instead, the union of d-sepsets between a subnet and all its neighbour subnets will be su cient to guarantee that. The union of d-sepsets between a subnet and all its`neighbour' subnets d-separates variables in the subnet from variables in the neighbour subnets, and allows all the`relevant' information to be passed between them 27].
in Figure 1 is sectioned into a MSBN f 1 ; 2 ; 3 g in Figure 2 . Figure 2 : An multiply sectioned Bayesian network from in Figure 1 Sectioning should have a`sound' overall structure in order to guarantee correct inference. Intuitively, the structure of a MSBN should ensure that evidence acquired in any subnet be able to propagate to a di erent subnet through a unique chain of subnets. One rule for a sound sectioning is to have a covering subnet which contains all the d-sepnodes between each pair of subnets. A more general rule called`hypertree' is discussed in 27] which requires only local covering subnets, and a tree structure between the subnets. The MSBN in Figure 2 has a covering subnet 1 since S 1 I 12 I 13 I 23 . Therefore, the sectioning is sound.
Once a MSBN has been constructed, we construct probability distributions for each subnet such that a joint distribution equivalent to that of the entire homogeneous network is speci ed. See 27] for details. Transformation of a MSBN to a junction forest requires moralization 4 and triangulation 5 as in other secondary representations 14, 12] . But the modular representation of MSBNs allows the performance of these operations by local computations. This reduces the space requirement to the size of the maximal subnet. Communications between subnets are necessary to ensure correct local computations. For example, after moralization and triangulation, the MSBN in Figure 2 is transformed into the set of triangulated graphs f 1 ; 2 ; 3 g in Figure 3 . Each undirected graph (i.e., a moralized and triangulated graph) is converted to a junction tree 6 . Transformation of an undirected graph into a junction tree structure allows e cient computation during diagnostic inference. The transformation is performed in the same way as in 1, 12] .
For example, f 1 ; 2 ; 3 g in Figure 3 is transformed into f? 1 ; ? 2 ; ? 3 g in Figure 4 .
To nish the structure of the MSBN, we create linkages between the covering subnet and others. A linkage is the intersection of two cliques in di erent junction trees. The union of all linkages between two adjacent trees equals the d-sepset between them. With linkages created, the set of junction trees becomes a linked junction forest. A junction forest consists of a set of linked junction trees, each of which corresponds to a localization preserving subdomain and can be used separately during inference computation. Note that a junction forest allows multiple linkages between a pair of junction trees. These linkages serve as the information channels between junction trees that are used to transfer evidence from one tree to another. For example, in Figure 4 , linkages between junction trees are indicated with ribbed bands. There is one linkage between clique 1 of ? 1 and clique 2 of ? 2 , namely, fH 1 ; H 2 g. The two linkages between ? 1 and ? 3 are fH 2 ; H 3 g and fH 3 ; H 4 g. 4 A Bayesian network is moralized if, for each node, links are added between all its parent nodes and directions on the links are dropped. After moralization, a Bayesian network becomes an undirected graph. 5 An undirected graph is triangulated if every cycle of length > 3 has a chord. A chord is a link connecting two nonadjacent nodes. 6 A maximal set of nodes all of which are pairwise linked is called a clique. The nodes in the junction tree are cliques of the corresponding undirected graph. Finally we construct belief tables for each of the cliques and linkages such that a joint distribution for the junction forest equivalent to that of the MSBN is speci ed. See 27] for details.
Using the Junction Forest in a Diagnosis
A set of object-oriented operations 27] are de ned to perform inference in the linked junction forest. The inference is performed by having one active junction tree. When we want to add evidence or post queries to another junction tree, we shift our attention from the current tree to the target tree.
The operation BeliefInitialization initializes the belief tables of the linked junction forest such that the marginal distribution of each variable can be obtained by local computation at a clique which contains the variable. The initialized forest becomes the permanent representation of the domain and will be reused for each query session.
The operation EnterEvidence is performed to enter evidence into the currently active junction tree and to bring the tree into consistency. Posterior marginal distributions in the active tree can then be obtained by local computation. In the case of incremental evidence, EnterEvidence can be applied several times. This is performed in the same way as in 12]. However, in 12], the evidence is propagated to the entire homogeneous network. With the junction forest representation, computational savings are gained by not having to compute all the currently inactive subnets.
The operation ShiftAttention is used to bring a di erent junction tree of user's attention into active focus. In the case where a covering subnet exists, ShiftAttention swaps in and out the covering subnet, and then the target subnet to propagate all the relevant information. In the more general case where the MSBN has an overall`hypertree' structure, the set of`intermediate' trees between the previously active tree and the target tree need to be updated. Computational savings are gained by not having to update any of the non-intermediate trees. The posterior marginal distributions in the newly active tree can now be obtained by local computation. They are identical to what would be obtained in a homogeneous network.
In 12], a global consistency with respect to the entire homogeneous network is maintained before each query is answered. In a junction forest, consistency is maintained with respect to only the subnet of user's current attention. Computational saving are thus gained with no loss of accuracy in answers to queries.
All the above computations consider only one junction tree at a time. No matter how large the overall system, computational requirements are governed by only one subnet/junction tree. This often leads to computational savings in both time and space.
Applying MSBNs to the PAINULIM Domain
This section discusses why MSBNs are natural to the PAINULIM domain, and describes the bene ts obtained by adopting a MSBN representation.
Using the MSBN representation, we have partitioned the PAINULIM domain into three natural localization preserving subdomains (clinical, EMG and nerve conduction) which are separately represented by three Bayesian subnets: CLINICAL, EMG, and NCV ( Figure 5 ). Abbreviated names are used in Figure 5 . For example, the disease node Cts represents carpal tunnel syndrome, Rc81 represents C8T1 root disease, and Mnd represents motor neuron diseases which include anterior horn cell disease and amyotrophic lateral sclerosis. The feature node pn frm represents pain in forearm, and umcv represents ulnar motor conduction velocity. Figure 6 illustrates the corresponding linked junction forest.
MSBNs require that the interface between each pair of subnets is a d-sepset (Section 4.1). In PAINULIM, the three subnets are interfaced by the disease variables which they share. Topologically, the d-sepset criterion requires that every d-sepnode have all its parents contained in either one of the two subnets. In PAINULIM, disease variables are roots in each subnets without parents. The d-sepset condition is thus trivially true. Conceptually, evidence obtained from a di erent subdomain might be relevant to the subdomain of current interest, but this relevancy are summarized by the disease variables that the two subdomains share. That is, the disease variables separate the`interesting' from the`relevant'. This separating function is achieved through conditional independence which is enforced exactly by the d-sepset criterion.
The incidence of a disease can be in uenced by several factors like age, gendar, occupation, etc. The current version of PAINULIM has not considered these factors in its knowledge representation. If evidence is independent from these factors given the diseases, we need to add these variables as parents of disease variables and ensure that the parents for each disease are contained in the same subnet. Then the d-sepset condition is satis ed. In the case these factors also in uence the presentation of some evidence, we need to add these variables in the d-sepsets and again the d-sepset condition is satis ed.
MSBNs also require a sound sectioning. The PAINULIM representation satis es this condition through satisfying the covering subnet rule (Section 4.1). The CLINICAL subnet is the covering subnet which contains all the disease variables. This is natural in PAINULIM domain because at the stage of clinical examination an ENGer would be open to all the possible disease hypotheses. After the clinical examination, he usually narrows the number of hypotheses and chooses either EMG or nerve conduction studies to further di erentiate the hypotheses.
The MSBN is implemented in an expert systems shell WEBWEAVR 26], and WEBWEAVR is used for the development of PAINULIM. Adopting the MSBN representation in PAINULIM, we are able to provide users of PAINULIM with a natural interface, and to reduce the computational cost approximately by half relative to using a USBN approach (both space and time) taking into account the repetition of d-sepnodes and the computation required for attention shifts. The reduction of computational cost allows us to use hospital equipment (IBM-compatible PCs) to construct, re ne and run PAINULIM interactively with EMGers right in the hospital laboratory. This greatly speeded up the development of PAINULIM. It also enhances the system's usefulness to laboratory personnel. The label of each clique is generated by including only the rst letter of the name for each node in the clique. For example, the clique label Cm at the bottom is generated from Cts and mupl which are the names of two nodes contained in nerve conduction subnet in Figure 5 .
Further extension of PAINULIM may include other conventional tests in its representation. As mentioned in Section 2, the value of many EMG and nerve conduction feature variables are entered by system users based on their subjective interpretation of the recorded signals from EMG machines. Some of these values may be obtained by reasoning with quantities directly obtainable from EMG machines. This requires that the corresponding feature variables be connected to a new subnet at a lower abstraction level. With the MSBN representation, these extensions will not increase the requirement of computational resources since the computational cost of a MSBN is governed by the size of one subnet/junction tree, not by the size of the overall MSBN/junction forest.
Like other exact methods for inference in Bayesian networks, the MSBN requires sparseness of the network topology. With a sparse domain representation, MSBN exploits localization to gain additional computational savings. On the other hand, in a domain where variables are completely connected, there is no localization. We expect that many large domains, which can be represented by sparse Bayesian networks, can bene t from the MSBN representation. We are preparing to test the generality of localization and MSBN representation in other domains. 6 Other Issues in Knowledge Representation a or m': Not as alarming (absent or mild) as the above. A \wait and watch" attitude can be adopted.
A more re ned representation is one of our current goals for future extension.
6.2`Normal' and`other' diseases
An issue related to the above representation is how to handle unrepresented diseases. As stated earlier, currently PAINULIM represents the 14 most common diseases of the spinal cord and/or peripheral nervous system which present with a painful or impaired upper limb. The diseases in this category that are not represented in PAINULIM include: posterior interosseous nerve lesions, anterior interosseous nerve lesions, axillary nerve lesions, musculocutaneous nerve lesions, suprascapular nerve lesions, and long thoracic nerve lesions. They are not represented in the current version of PAINULIM because their combined incidence is less than 2%. Other Bayesian network based systems (e.g. PATHFINDER 10] and MUNIN 1]) have used`normal' and other' to represent`no disease' and`other diseases' respectively. A`normal' outcome is used to signal the situation where none of the features is abnormal. The semantics of`other' is to explain every possible feature pattern uncounted by the diseases explicitly represented.
A medical expert system is typically consulted for a patient who has some complaints. A`normal' outcome dedicated to the case where everything is normal seems to be unnecessary. The usefulness of a medical expert system comes out of its capability to identify diseases such that a proper management can be made. In the case that`other' is given as the explanation of complaints, a de nitive management cannot be made. Based on these consideration, PAINULIM does not distinguish`no disease' and`other diseases'. We represent only the diseases that we want to explicitly represent and exclude`normal' and`other' from our explicit representation.
Given a patient with abnormal features, if every disease represented shows high posterior probability for outcomè a or m', then it is interpreted as su ering problems outside the expertise of the current system. The behavior of PAINULIM with unrepresented diseases has been tested in our evaluation which is reported in Section 7.
Handling Spatial Distribution of Diseases
Neuromuscular diseases spatially distribute along the peripheral nervous system. Each disease involves lesions in certain nerve segment(s). Two aspects of knowledge are mostly involved in an EMGer's daily diagnoses. One is the causal relation of di erent lesions with corresponding signs and test outcomes. Another is the understanding of neuroanatomy. The anatomical knowledge enters into diagnosis in the following way: a proximal lesion (at a location closer to the centre of body) is likely to produce symptoms which characterize a distal lesion (at a location further away from the centre of body) along the same nerve, but the reverse is not true.
Based on the way in which anatomical knowledge is used in EMGer's practice, we explore the reasoning pattern \explaining away" 18] intrinsic to probability theory and Bayesian network representation. In our network representation, a proximal lesion tends to cause more abnormal signs and test outcomes than a distal lesion. When a patient presents with a feature pattern typical to a distal lesion, the lesion gets enough evidential support and its posterior probability becomes high. While a proximal lesion on the same nerve remains unlikely (explained away) due to insu cient support. On the other hand, if a patient presents with a feature pattern typical to a proximal lesion, the proximal lesion receives strong support and becomes highly likely, the distal lesions on the same nerve cannot explain all the features and will be explained away.
To our knowledge, there is no other system that explicitly exploits explaining away to represent the spatial distribution of diseases. We nd it important to explain this to domain experts, as it facilitates knowledge acquisition and system testing. Our experience with PAINULIM makes us believe that many medical domains where diseases are naturally organized into a hierarchy (spatially or anatomically) can be properly represented this way. 7 An Evaluation of PAINULIM
Case Selection
Seventy six patient cases in NDU were selected. They had been diagnosed by EMGers before being used in the evaluation. Patients (`normal' patients 7 ) whose complaints are diagnosed as caused by problems other than neuromuscular diseases and patients of carpal tunnel syndrome (Cts) occupy the majority of the patient population in the NDU of VGH. A case population taken according to natural sequence would not cover properly all the diseases represented in PAINULIM. An evaluation based on such a population would be over-optimistic as we had found that PAINULIM performed very well for`normal' and Cts cases during system testing. We instead selected the case population such that for each rare disease there was at least one case. We scanned sequentially the cases, which were diagnosed in a few months around the end of 1990 and which presented with a painful and impaired upper limb. After we had selected a few cases with the same disease, we skipped a few cases for this disease. Both typical and di cult cases were included for each disease. Table 1 lists numbers of cases involved for each disease. If a case involved multiple diseases, that is, either the patient was diagnosed as su ering from multiple diseases or di erentiation among several competing disease hypotheses could not be made at the time of diagnosis, then the count for each disease involved was increased by 1. The total count is 124. Thus the ratio 124=76 = 1:6 serves as an indication of the number of multiple diseases in the case population. Three cases (labelled`Unrepresented' in Table 1 
Performance Rating
In evaluating PATHFINDER, Ng and Abramson 16] used`classic' cases with known diagnoses. The agreement between the known diagnosis and the disease with top probability was used as an indicator of PATHFINDER's performance. Heckerman 10] asked the expert to compare PATHFINDER's posterior distributions with his own and to give a rating between 0 to 10. He also evaluated PATHFINDER with a decision-theoretic metric using an expert-generated`gold-standard' distribution based on features observed by another pathologist.
In evaluating PAINULIM, we want to compare it's performance with the diagnoses made by a pool of EMGers who practised in NDU of VGH. This is appropriate since there exists a database in natural language which well documents the symptoms, test results and diagnosis for each previous patient in NDU. 8 In the PAINULIM domain, a human diagnosis can indicate an absence of neuromuscular disease, or the presence of a single disease, or the presence of multiple diseases. Each disease can be judged as being in di erent degrees of severity. Sometimes the human diagnosis is uncertain because the test studies are not well designed or incomplete. On the other hand, the current version of PAINULIM represents a disease as binary:`a or m' or`m or s' (Section 6.1). Therefore the central issue of evaluation is how to map the posterior distributions (on binary variables) produced by PAINULIM to the EMGer' diagnosis expressed in di erent severity and con dence.
In the PAINULIM domain, there is no certain way to know the`real' state of disease(s) given a patient case. One could compare the expert system with EMGers and take the EMGers' judgments as the gold standard. Since no EMGer is perfect, the evaluation conducted this way may have its limitation. Both the system and the EMGer may make the same error, or the system may be correct while the EMGer makes an error. To address the limitation, when there was con ict between the diagnoses made by the original EMGer and PAINULIM, we consulted a second EMGer. The motivation was that the second EMGer, faced with a con ict, would examine the evidence more carefully and hopefully come up with a decision with better quality. When there is disagreement in diagnoses between two EMGers, consultation of a third EMGer is a common practice. Since we were con ned by the time and the people who participated in this project, two of us (A.E. and B.P.) acted as the second EMGer. In the following discussion, when we refer to the second EMGer, we will say so explicitly.
For each case, the patient documentation was examined and the values for feature variables were entered to PAINULIM to compute posterior distributions for all diseases represented.
To compare the EMGer's diagnosis with that of PAINULIM, the following procedure was used for each case: 1. Identify the set S of disease variables included in the EMGer's diagnosis. This set is the union of the set of diseases represented in PAINULIM (call it S 1 ), and a set S 2 of diseases that appeared in the patient le as the EMGer's diagnosis but not represented in PAINULIM. The diseases in S 2 were in fact used to test PAINULIM's performance on diseases it does not explicitly model.
2. Assign the state for each disease in S consistent with the EMGer's diagnosis. If the disease was mentioned in the patient le, the state was determined by the EMGer's statement in natural language that the disease was mild, or moderate, or severe, or uncertain. Otherwise, presumably, the EMGer judged the disease as absent.
3. Seven rules were de ned to rate the performance of PAINULIM at each disease in S relative to the EMGer's diagnosis. Only one of the rules was applied to a disease. Rating scales were: superior (SP), excellent (EX), good (GD), fair (FR), poor (PR) and wrong (WR). Rule 1 to 4 were general rules. Their applicability to a disease was determined according to only the EMGer's diagnosis (the state of the disease in S). The following conditions determined the rst four rules. Rule i is that if Cond i holds, then the rating can be obtained by looking at the appropriate value in Figure 7 , given PAINULIM's posterior probability.
Cond 1: The disease was judged by the EMGer as moderate or severe. Cond 2: The disease was judged by the EMGer as absent or mild. Cond 3: The disease is not represented by PAINULIM but was judged by the EMGer as the single disease diagnosis of the case in question.
Cond 4: The disease was judged by the EMGer as uncertain because of evidence which could not be easily explained, or the disease's anatomical site was close to that suspected by the EMGer. There are three other rules that dealt with situations where the EMGer's diagnosis di ered from PAINULIM's diagnosis. These rules had higher priority over Rule 1 to 4. Their applicability to a disease was determined by both the EMGer's diagnosis and PAINULIM's distribution for the disease. In these rules, we distinguish`the EMGer' who made the diagnosis previously and might have left NDU at the time of evaluation, from the`second EMGer' who was consulted at the time of evaluation.
Rule 5 If a disease had p(D = m or sjevi:) > 0:7 by PAINULIM, and the disease was di erent from the original EMGer's diagnosis, and PAINULIM's diagnosis was agreed upon by a second EMGer to whom only the evidence as presented to PAINULIM was available, then the PAINULIM's performance for this disease was rated GD.
Rule 6 If a disease had p(D = m or sjevi:) > 0:7 by PAINULIM, and the disease was di erent from the original EMGer's diagnosis, and the PAINULIM's diagnosis was agreed upon by a second EMGer to whom the con ict was presented, then the PAINULIM's performance for this disease was rated SP.
Rule 7 If PAINULIM assigned p(D = m or sjevi:) between 0.7 and 0.3 for a disease D based on evidence ignored by the original EMGer, and a second EMGer considered the evidence for this disease signi cant and agreed with PAINULIM, then the PAINULIM's performance for this disease was rated SP. 4. For each disease in S, the applicable rule was selected and PAINULIM's performance for this disease was rated by the rule. As noted above, rules 5, 6 and 7, when applicable, overwrite rules 1, 2, 3, and 4. 5. After the rating for each disease was assigned, the lowest rating was given as the rating of PAINULIM's performance for the case in question. Having presented the evaluation procedure, some explanation of the seven rules is appropriate. For each represented disease, applications of Rule 1, 2, and 4 involved the comparison of the decision range with the distribution for the disease by PAINULIM. For each unrepresented disease, the application of Rule 3 involved the comparison of the decision range with the distribution for each disease represented by PAINULIM. The intuition was that PAINULIM should not confuse the unrepresented disease with any represented disease.
Rules 1, 2 and 3 correspond to the situation where the EMGer had a con dent diagnosis. Note that, the corresponding decision ranges in Figure 7 were uniform. The intuition for these rules was that we treated the EMGer's diagnosis as the gold standard if the case was well within his expertise so that he was con dent about the diagnosis. For Rule 1, if PAINULIM generated high probability then its behavior was considered satisfactory. The lower the probability, the less satisfactory. For Rule 2 and 3, low probabilities from PAINULIM was desired (p(D = m or sjevi) = low corresponds to p(D = a or mjevi:) = high). Rule 3 corresponds to the situation where PAINULIM performed on a disease it does not explicitly model (Section 6.2). Since the disease was unrepresented, PAINULIM should behave the same as Rule 2.
Rule 4 corresponds to the situation where the EMGer had an uncertain diagnosis. Note that the decision range is uniform except a wider range of EX. The intuition was that since the EMGer was uncertain about the severity of the disease, PAINULIM should also give a warning but should not be overcommitted with the insu cient evidence.
As mentioned in Section 2, PAINULIM currently works mostly at the anatomical level and cannot process much of the etiological and pathological evidence. Rule 5 handled the situation where the human diagnosis was arrived at by nonanatomical evidence not represented in PAINULIM. Acknowledging the limitation, instead of failing PAINULIM in these cases, we would like to know if the diagnosis was acceptable at the current level of representation. Such cases, however, amount to only four out of the total 76. When the rule condition was satis ed and unrepresented evidence was present in the patient le, the list of symbolic features as presented to PAINULIM, together with PAINULIM's diagnosis, was presented to the second EMGer. Whether or not he agreed with the diagnosis was asked.
Rules 6 and 7 were designed to identify situations where PAINULIM behaved superior to the original EMGers. When the rule condition was satis ed, the full patient le (including the original EMGer's diagnosis) and the PAINULIM's diagnosis were presented to the second EMGer. Whether he agreed with one or the other was asked. To avoid bias, when the rule succeeded, the second EMGer had to state explicitly the particular pieces of evidence which lead to his disagreement with the original EMGer and to his agreement with PAINULIM. The pieces of evidence were recorded for later inspection. Out of 76 cases, PAINULIM showed superior behavior in twelve cases ( ve by Rule 6 and seven by Rule 7).
In steps 1 and 2 of our procedure, we extracted the original EMGer's most likely composite hypothesis 18] from the database. The hypothesis is over the set S excluding the diseases judged as uncertain. Our comparison in steps 4 and 5 was performed based on only marginal probabilities, not the joint probability over S. It has been proved 29] that when the marginal probability of an outcome of a variable is high enough, this outcome must be the value of the variable in the most likely composite hypothesis containing the variable. The mathematical detail regarding how high is enough is presented in 29].
Evaluation Results
The evaluation of 76 patient cases has the following outcomes: SP: 12, EX: 49, GD: 9, FR: 3, PR: 1, WR: 2. The EX or SP rate is 0.80 with 95% con dence interval being (0.695, 0.885) using a standard statistic technique (estimation for con dence intervals in Bernoulli trials 13]). The GD or EX or SP rate is 0.92 with 95% con dence interval being (0.836, 0.971). More detailed results are listed in Table 2 .
Cases by EMGer's Diagnosis SP EX GD FR PR WR subtotal con dent, normal 1 9 10 con dent, single mild disease 2 3 1 1 7 con dent, single mod. or sev . 2 23  2 2  29  con dent, multiple diseases  2  4  2  1  1  10  single unrepresented disease  1  1  1  3  uncertain diagnosis  5  9  3  17  subtotal  12 49  9 3 1  2  76   Table 2 : PAINULIM evaluation results
Discussion of Evaluation Results
For the 56 cases in which original EMGers' diagnoses were con dent, PAINULIM performed well when either a single disease was involved or no neuromuscular disease was present (GD or better: 53, FR: 3). For twelve cases, PAINULIM's behavior was rated SP. In seven of them, PAINULIM indicated a second disease which was not counted properly by the EMGer. Careful examination of the feature presentation by the second EMGer showed that the original diagnosis indeed failed to explain the corresponding features. For example, in one case, the EMGer diagnosed the patient as having mild ulnar nerve lesion (Ulrnn), and PAINULIM generated p(Ulrnn = m or sjevi:) = 0:06 and p(Cts = m or sjevi:) = 0:45 which warned the presence of carpal tunnel syndrome (Cts). After examining the documentation by the second EMGer, it was found that the original EMGer had not explained the reason for the low amplitude of median sensory potential which was considered due to Cts by PAINULIM.
In the other ve cases out of the twelve, PAINULIM provided diagnoses signi cantly di erent (di erent disease or di erent severity) from the EMGers' diagnoses. The examination by the second EMGer showed that PAINULIM's diagnoses took better account of the evidence.
For 17 cases, the EMGer's diagnosis was either uncertain about the possible diseases, or was con dent about the major disease but uncertain about the presence of minor diseases. PAINULIM usually indicated several candidates best matching the available evidence which provided hints for a more complete test study. In ve cases out of the 17, PAINULIM's performance was rated SP. This shows that when cases are di cult, PAINULIM might be quite useful to EMGers.
For the two cases diagnosed as a disease in the spinal cord or peripheral nervous system but not represented in PAINULIM, PAINULIM's performance was EX for one and GD for the other. In these two cases, p(D = a or mjevi:) for every disease D was greater than 0.75. This was interpreted as saying the patient was not in a moderate or severe state for any represented disease, and was su ering from other problems (Section 6.2). The evaluation showed that outside the domain of representation, PAINULIM does not confuse a disease with represented diseases whenever the unrepresented disease has its unique feature pattern.
On the other hand, the evaluation revealed several limitations of PAINULIM. One limitation related to unrepresented diseases. One case in evaluation was diagnosed by the EMGer as central sensory loss which was a disorder in the central nervous system. It was outside the PAINULIM domain but also characterized by a painful or impaired upper limb. When restricted within the PAINULIM domain, the disease presentation was similar to radial nerve lesion (Radnn). PAINULIM could not di erentiate and had p(Radnn = m or sjevi:) = 0:62 (the rating is WR). This de ciency calls for the expansion of current PAINULIM domain.
PAINULIM works with limited variables. For example, in the clinical subnet, the variable`lslathnd', which represents loss of sensation in the lateral hand and/or ngers, does not allow a distinction between the front of the hand (median nerve, carpal tunnel syndrome or C67 root disease) and the back of the hand (radial nerve lesion, plexus posterior cord, C67 root disease). When evidence comes towards one of them but not the other, instantiation of lslathnd will enforce (incorrectly) a group of diseases. Part of our current e ort is to further re ne our representation of features. This and the following point were the major reasons for the degradation of performance in the case of multiple diseases (one PR and one WR out of 10).
Unsatisfactory performance in some cases was due to the inaccuracy of numerical probabilities. One source of the inaccuracy originated from the experts' limited experience with certain diseases. When a disease is very rare (for example, intrinsic cord disease), the EMGer giving the probabilities may have little experience with the disease and thus provide an inaccurate assessment. A few cases rated as FR or PR or WR were due to inappropriate assessment of conditional probabilities. Further re nement and incorporation of a learning facility 24] are planned for a future version of PAINULIM.
The preliminary evaluation has the following limitations: First, it was performed when PAINULIM had only restricted levels of knowledge representation. As stated earlier, PAINULIM works mostly at the anatomical level and most of the pathological and etiological evidence can not yet be processed. In four out of 76 cases in the evaluation, the ratings were made based on unrealistic situations where the pathological and etiological evidence in the patient cases were removed.
Second, the evaluation used retrospective cases to which the original diagnoses were available. As mentioned in subsection 7.1, this information was used to obtain an adequate number of cases for each represented disease in the selected cases. An evaluation of PAINULIM based on prospective cases would probabily only use a painful or impaired upper limb as the criterion for case selection. Although we expect an overall better performance of PAINULIM in that situation as explained in subsection 7.1, it remains a hypothesis to be tested. Third, restricted by the available resource, and in uenced by the preliminary nature of the evaluation, the evaluators in this evaluation were also the developers of PAINULIM. This might introduce bias to the results, even though e orts had been made to reduce the bias as much as possible. Finally, it remains to be seen, after further extension, that how PAINULIM's output will in uence practising EMGers' diagnostic accuracy.
Conclusions
Bayesian networks provide a natural, concise knowledge representation method and a consistent inference formalism for building diagnostic expert systems. Using this formalism, we have been able to represent the diagnostic knowledge at the anatomical level in the domain of neuromuscular diagnosis of patients with a painful or impaired upper limb. This includes the representation of multiple diseases distributed spatially. There have been several expert systems developed in the domain of neuromuscular diagnostic domain in the last decade. But there has been no other such system that has reached the stage of clinical evaluation using a large number of patient cases as has PAINULIM. The performance of PAINULIM supports the notion that a probabilistic approach can be appropriate for some large medical applications.
Substantial advances have been made in probabilistic reasoning using Bayesian networks. However, exact computation in large application domains still incurs large computational overhead. Knowledge acquisition and system testing at medical doctors' work sites can speed up the development of medical expert systems. This is facilitated by systems that can be implemented using inexpensive computational resources commonly available in hospitals. The possibility of deployment of large systems using such resources also increases the usefulness of these systems.
The homogeneous representation of Bayesian networks is a problem we have addressed. We have developed a general solution (MSBN) 27] to the problem and have applied it to PAINULIM by representing and exploiting localization naturally existing in this domain. This allowed reduction of computational cost with no loss of inference accuracy. The MSBN representation also potentially supports the further extension of PAINULIM without the requirement of upgrading computational resources.
We indicate that the applicability of MSBNs in a domain does not require the sharing of all the features of the PAINULIM domain. Although our experience with MSBN is from the domain of neuromuscular diagnosis, we believe that localization is a general feature, and we are preparing to test its generality in other large domains.
